Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial)

Abstract Background Eighty percent of children with steroid-sensitive nephrotic syndrome (SSNS) relapse within 2 years and 40–50% patients show frequently-relapsing nephrotic syndrome (FRNS). Patients showing a relapse within 6 months after initial remission are at high risk of FRNS. Since frequent...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Taketsugu Hama, Koichi Nakanishi, Kenji Ishikura, Shuichi Ito, Hidefumi Nakamura, Mayumi Sako, Mari Saito-Oba, Kandai Nozu, Yuko Shima, Kazumoto Iijima, Norishige Yoshikawa, for the Japanese Study Group of Kidney Disease in Children (JSKDC)
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2018-09-01
Edice:	BMC Nephrology
Témata:	Mizoribine Frequently-relapsing nephrotic syndrome Steroid-sensitive nephrotic syndrome
On-line přístup:	http://link.springer.com/article/10.1186/s12882-018-1033-z
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!